Monday 3rd - Thursday 6th July 2006, NH Barbizon Palace, Amsterdam

Novel methodologies used to identify and characterise antibodies will be assessed by industry leaders, latest regulatory requirements for assays validation will be clarified, new models for early prediction of immunogenicity will be introduced and recent clinical case studies will be showcased.
Click here for more details
http://www.iir-events.com/IIR-Conf/page.aspx?id=1405

Confirmed speakers already include:

- Shalini Gupta, Associate Director Clinical immunology, Amgen

- Robin Thorpe, Head, Division of Immunology &Endocrinology, National - Institute For Biological Standards and Control

- Nadja Prang, Director of Bioanalytical Development, Serono

- Huub Schellekens, Director, General Animal Laboratory, University of Utrecht

- Anne S. de Groot, President and CEO, Epivax Inc

- Maria Barbosa, Group Leader, Xencor INC.

- Harald Kropshofer, Head Non-clinical Immunology & Global Coordinator Immunosafety of Biologicals, F. Hoffmann La Roche

- Herman Waldmann, Head, Therapeutic Immunology Group, University of Oxford

- Deborah Finco-Kent, Immunoassay Coordinator Immunotoxicology Lab, Safety Sciences, Pfizer



PLUS... Expand your knowledge and improve your skills by attending our two interactive Pre and Post Conference Workshops:

3 easy ways to register:

_ Call IIR customer services +44 (0)20 7915 5055, remember to quote conference code CQ6009

_ Email registration@iir-conferences.com

_ Visit http://www.iir-events.com/IIR-Conf/page.aspx?id=1405